Orgenesis Inc. (ORGS) Forward P/S Multiple

Corporate emblem and logo of Orgenesis Inc. (ORGS)

High adaptation costs for centers are constraining operational growth, which supports the future P/S of Orgenesis Inc. (ORGS). The value 15.10 serves as the current value for this metric's parameter. Orgenesis Inc. is implementing software for the local production of cell therapies to minimize logistical risks. Business scaling relies on cloud hosting and external integrators for the rapid deployment of systems within clinics.

ORGS Orgenesis Inc: Market Cap to Expected Sales Ratio in the range 07/04/2022 - 10/26/2024

Analytical breakdowns for Orgenesis Inc.

- market price and analyst price targets:
Price Chart Orgenesis|ORGS - Analyst Median Target
- market capitalization details:
Market Capitalization Orgenesis Corporation|ORGS - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share Orgenesis|ORGS - Book Valuation of Business|Market Cap to Net Assets Ratio orgenesis.com|ORGS - Aggregate Asset Value
- company liabilities and liquidity data:
Total Debt to Capital Orgenesis Inc.|ORGS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Orgenesis Inc.|ORGS - Company Aggregate Debt|Debts to Book Capitalization Orgenesis Corporation|ORGS - Company Long-Term Liabilities|Company Current Liabilities Orgenesis|Quick Liquidity orgenesis.com
- business earnings and investment ratios data:
ORGS - Company Net Income|Expected Profit Orgenesis Inc.|ORGS - Company Value to Net Income|Forward P/E Multiple Orgenesis Corp|ORGS - Price to Net Income Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Orgenesis Corporation|ORGS - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Orgenesis|ORGS - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months orgenesis.com|ORGS - Net earnings per one share growth for the current year|Expected earnings per share growth for next year Orgenesis Inc.
- sales volume and revenue indicators:
ORGS - Company Sales Revenue|Company Projected Revenue Orgenesis|ORGS - Market Cap to Revenue|Forward P/S Multiple Orgenesis Corporation
Fundamental company valuation:Orgenesis ORGS
Product sample of Orgenesis Inc.

For the non-cyclical cell therapy business of Orgenesis Inc. (ORGS), the forward P/S multiple serves as an indicator of market expectations regarding revenue scaling rates. This ratio compares current market capitalization with projected sales volume, allowing investors to assess the premium paid for future growth and determine the fundamental capital stability of the issuer within the context of long-term medical planning.

Competitors of Orgenesis Inc. (ORGS)

Price-to-Projected Revenue Ratio Veeva VEEV|Market Cap to Expected Sales Ratio Doximity Inc (DOCS)|HealthEquity Corp - Forward P/S Multiple|Market Cap to Expected Sales Ratio Waystar Corp WAY|CorVel Corporation (CRVL) - Price-to-Projected Revenue Ratio|PRVA - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple HURN|CERT: Forward Price to Sales|Forward P/S Multiple OMCL|Market Cap to Expected Sales Ratio GoodRx Gold|Price-to-Projected Revenue Ratio Schrodinger, Inc. SDGR|PHR: Market Cap to Projected Revenue|Omada Health - Forward P/S Multiple|Evolent Health Inc (EVH) - Forward Price-to-Revenue Multiple|HSTM (HealthStream Corp) - Forward Price-to-Revenue Multiple|DH - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Consensus Cloud Solutions|Market Cap to Future Revenue Ratio agilonhealth.com AGL|Price-to-Projected Revenue Ratio Absci Corporation (ABSI)|SY (So-Young International Inc) - Forward Price to Sales|Forward P/S Multiple NRC (National Research Corporation)|Projected Price to Revenue USA Mobility|OPRX - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio trubridge.com TBRG|SLP: Forward P/S Multiple|SOPH - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple HCAT|CCLD (CareCloud Corp) - Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple RSSS (Research Solutions)|DLHC (dlhcorp.com) - Forward Price to Sales|Price-to-Projected Revenue Ratio OneMedNet ONMD|SCNX - Forward Price-to-Revenue Multiple|Healthcare Triangle Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio iSpecimen Inc.|BFRG: Forward P/S Multiple|Market Cap to Projected Revenue WORX|Price-to-Projected Revenue Ratio MSP Recovery|Market Cap to Future Revenue Ratio iCoreConnect Corp ICCT|Price-to-Projected Revenue Ratio TRxADE (MEDS)|RCM (r1rcm.com) - Forward Price to Sales|Forward P/S Multiple SHCR (Sharecare, Inc.)|Projected Price to Revenue streamlinehealth.net|Syra Health - Forward P/S Multiple|Market Cap to Future Revenue Ratio Apollo Medical Holdings|Model N Corp (MODN) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue NXGN